Studien & Quellen

1. Zhang, L. et al. (2020): Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis. Journal of Cancer 11(1): 177-189.
2. Roehrborn, C. G. (2005): Benign Prostatic Hyperplasia: An Overview. Nature Reviews Urology 7(9): 3-14.
3. Madersbacher, S. et al. (2019): Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Gerontology 65(5): 458-464.
4. Zhang, Q. et al. (2020): Association between Inflammation and Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia. The Journal of Urology 17(5): 505-511.
5. Oelke, M. et al. (2013): EAU Guidelines on treatment and follow up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology 64: 118-140.
6. Kardasevic, A., S. Milicevic (2016): The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction. Medical Archives 70(6): 449-452.
7. Rosen, R. et al. (2003): Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). European Urology 44(6): 637-649.
8. Kirby, M. et al. (2013): Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. International Journal of Clinical Practice 67(7): 606-618.
9. Rosen, R. et al. (2005): Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). European Urology 47(6): 824-837.
10. Rosen, C. (2006): Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Current Opinion in Urology 16(1): 11-19.
11. Michel, M. S. et al. (2016): Die Urologie. 1. Auflage, Springer Verlag.
12. Berry, S. J. et al. (1984): The development of human benign prostatic hyperplasia with age. The Journal of Urology 132(3): 474-479.
13. Rosen, R. et al. (2003): Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). European Urology 44(6): 637-649.
14. Ng, M., K. M. Baradhi (2021): Benign Prostatic Hyperplasia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
15. Roehrborn, C. G. (2005): Benign Prostatic Hyperplasia: An Overview. Nature Reviews Urology 7(9): 3-14.
16. Berry, S. J. et al. (1984): The development of human benign prostatic hyperplasia with age. The Journal of Urology 132(3): 474-479.
17. Zhang, Q. et al. (2020): Association between Inflammation and Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia. The Journal of Urology 17(5): 505-511.
18. Vignozzi, L. et al. (2014): Benign prostatic hyperplasia: a new metabolic disease? Journal of Endocrinological Investigation 37(4): 313-322.
19. Bushman, W. A., T. J. Jerde (2016): The role of prostate inflammation and fibrosis in lower urinary tract symptoms. American Journal of Physiology-Renal Physiology 311(4): F817-F821.
20. Schenk, J. M. et al. (2010): Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial. American Journal of Epidemiology 171(5): 571-582.
21. Oelke, M. et al. (2013): EAU Guidelines on treatment and follow up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology 64: 118-140.
22. Kardasevic, A., S. Milicevic (2016): The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction. Medical Archives 70(6): 449-452.
23. Kardasevic, A., S. Milicevic (2017): Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction. Medical Archives 71(1): 32-36.
24. Zhang, L. et al. (2020): Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis. Journal of Cancer 11(1): 177-189.
25. Pietrzyk, B. et al. (2015): Depressive symptoms in patients diagnosed with benign prostatic hyperplasia. International Urology and Nephrology 47(3): 431-440.
26. Lai, H. et al. (2019): Management of symptom flares and patient-reported flare triggers in interstitial cystitis/ bladder pain syndrome (IC/BPS) – Findings from one site of the MAPP Research Network. Urology 126: 24-33.
27. Shorter, B. et al. (2007): Effect of comestibles on symptoms of interstitial cystitis. The Journal of Urology 178(1): 145-152.
28. Schimpf, M. O. et al. (2020): Fluids affecting bladder urgency and lower urinary symptoms (FABULUS): methods and protocol for a randomized controlled trial. International Urogynecology Journal 31(5): 1033-1040.
29. Bykoviene, L. et al. (2018): Pelvic Floor Muscle Training With Or Without Tibial Nerve Stimulation and Lifestyle Changes Have Comparable Effects on The Overactive Bladder. A Randomized Clinical Trial. Urology Journal 15(4): 186-192.
30. Hagen, S. et al. (2020): Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT. Health Technology Assessment 24(70): 1-144.
31. Weber-Rajek, M. et al. (2020): Assessment of the Effectiveness of Pelvic Floor Muscle Training (PFMT) and Extracorporeal Magnetic Innervation (ExMI) in Treatment of Stress Urinary Incontinence in Women: A Randomized Controlled Trial. BioMed Research International 2020, Article ID 1019872, 7 pages.
32. Silva, V. et al. (2019): Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database of Systematic Reviews 4, Art. No. CD012044.
33. Busch, W., A. Holzmann (2001): Veterinärmedizinische Andrologie. Physiologie und Pathologie der Fortpflanzung bei männlichen Tieren. Schattauer Verlag.
34. Prentner, A. (2017): Heilpflanzen für Niere, Blase und Prostata. In: Heilpflanzen der Traditionellen Europäischen Medizin, S. 237-270.
35. Christudoss, P. et al. (2011): Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma. Indian Journal of Urology 27(1): 14-18.
36. Sauer, A. K. et al. (2020): Zinc Deficiency in Men Over 50 and Its Implications in Prostate Disorders. Frontiers in Oncology 10: 1293.
37. Betrie, A. H. et al. (2021): Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle. Nature Communications 12: 3296.
38. Choi, H. K. et al. (1995): Clinical efficacy of Korean red ginseng for erectile dysfunction. International Journal of Impotence Research 7(3): 181-186.
39. Leung, K. W., A. St Wong (2013): Ginseng and male reproductive function. Spermatogenesis 3(3):e26391.
40. Brunetti, P. et al. (2020): Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. Pharmaceuticals 13(10): 309.
41. Liu, L. et al. (2020): Traditional uses, chemical diversity and biological activities of Panax L. (Araliaceae): A review. Journal of Ethnopharmacology 263:112792.
42. Sung, J. et al (2000): Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. The American Journal of Chinese Medicine 28(2). 205-216.
43. Pan, C. et al. (2012): Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. Vascular Pharmacology 56(3-4): 150-158.
44. Scott, G. I. et al. (2001): Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. British Journal of Pharmacology 134(6): 1159-1165.
45. Tocharus, C. et al. (2012): Butea superba (Roxb.) improves penile erection in diabetic rats. Andrologia 44(1): 728-733.
46. Manosroi, A. et al. (2006): Effects of Butea superba on reproductive systems of rats. Fitoterapia 77(6): 435-438.
47. Cherdshewasart, W., N. Nimsakul (2003): Clinical trial of Butea superba, an alternative herbal treatment for erectile dysfunction. Asian Journal of Andrology 5(3): 243-246.
48. Eumkeb, G. et al. (2017): The synergy effect of daidzein and genistein isolated from Butea superba Roxb. on the reproductive system of male mice. Natural Product Research 31(6): 672-675.
49. Goswami, S. K. et al. (2012): Screening for Rho-kinase 2 inhibitory potential of Indian medicinal plants used in management of erectile dysfunction. Journal of Ethnopharmacology 144(3): 483-489.
50. Zhang, L. et al. (2020): Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis. Journal of Cancer 11(1): 177-189.
51. Harvard Medical School (2011): ED pills and benign prostatic hyperplasia. Harvard Health Publishing. In: health.harvard.edu, 1. September 2011, <https://www.health.harvard.edu/mens-health/ed-pills-and-benign-prostatic-hyperplasia>, Abrufdatum: 31.01.2022.